FDA 483 - Far East Summit LLC - April 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Far East Summit LLC received a Form 483 with 22 observations detailing significant deficiencies in its dietary supplement manufacturing operations. The firm failed to establish adequate product and component specifications, conduct proper identity testing, and qualify suppliers, with several issues being repeat observations. Key concerns include unqualified quality control personnel, inadequate master and batch manufacturing records, poor hygienic practices, and a lack of effective controls against foreign material contamination.
ID · 29a7ee13-0b33-402a-859a-9b153ab66652